Skip to content

Clinical Trial for wound dressing.

Phase 2 studies for assessment of safety and efficacy of wound dressing (SKBPARA) comprising botanicals.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/012164
Enrollment
110
Registered
2018-02-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patient with wounds

Interventions

Intervention1: SKBPARA: Apply repeatedly wound dressing on wound. Control Intervention1: No comparator agent: Not applicable

Sponsors

SK Biolabs
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with wound(s).

Exclusion criteria

Exclusion criteria: Volunteers with no wound(s).

Design outcomes

Primary

MeasureTime frame
Facilitate fast healing of wound(s).Timepoint: 2 Days

Secondary

MeasureTime frame
Facilitate fast healing of wound(s).Timepoint: 10 Days

Countries

India

Contacts

Public ContactAshok Kumar

SK Biotherapeutics Pvt. Ltd. (Previously SK Biolabs)

ashok846@gmail.com8126688922

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026